Can anti–oxidants prevent ischaemic heart disease?

Antioxidants, cholesterol, and ischaemic heart disease: CHAOS or confusion?

Ischaemic heart disease.

There can be no truly objective frequency estimate of the susceptibility of the population to ischaemic heart disease: everybody has some degree of susceptibility. The disease kills 1 in 4 of the population, and 1 man in 10 dies of ischaemic heart disease before 65 years of age. The major burden is mortality, though there is often some degree of impairment among survivors of acute attacks. It i...

Homocysteine, lipid indices and antioxidants in patients with ischaemic heart disease from Maharashtra, India.

INTRODUCTION Geographical and ethnic factors have recently been shown to have a significant role to play in cardiovascular diseases. The exact relationship between nutritional and geographical factors in cardiovascular diseases is not very clear. This study examined the relationship of hyperhomocysteinaemia with lipid profile and antioxidants in patients with ischaemic heart disease from rural ...

Metabolomics and ischaemic heart disease.

Ischaemic heart disease accounts for nearly half of the global cardiovascular disease burden. Aetiologies relating to heart disease are complex, but dyslipidaemia, oxidative stress and inflammation are cardinal features. Despite preventative measures and advancements in treatment regimens with lipid-lowering agents, the high prevalence of heart disease and the residual risk of recurrent events ...

Non-atheromatous ischaemic heart disease.

Myocardial ischaemia may result from congenital abnormalities in the origin or distribution of the coronary arteries. Coronary obstruction may also develop at a young age in some rare hereditary disorders such as Hurler's syndrome, homocystinuria or pseudoxanthoma elasticum. The coronary arteries may be the site of embolism; ostial stenosis may complicate luetic (or other) aortitis or coronary ...